Kimberly C. Coleman

Statistics

Publications

Citations

264

H-Index

Active since

2018

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Brigham and Women's Hospital

Dana-Farber Cancer Institute

Beth Israel Deaconess Medical Center

Memorial Sloan Kettering Cancer Center

Kimberly C. Coleman is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, autologous stem cell infusion, and immunotherapy.

Publications per year

2018–2020

Publications

PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation

Philippe Armand, Yi‐Bin Chen, Robert Redd et al. · Blood · 2019 · 186 citations · Full text

Life Sciences, Immunology, Oncology +16

PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation

Matthew J. Frigault, Philippe Armand, Robert Redd et al. · Blood Advances · 2020 · 65 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

PD-1 Blockade with Pembrolizumab for Classical Hodgkin Lymphoma after Autologous Stem Cell Transplantation

Philippe Armand, Yi‐Bin Chen, Robert Redd et al. · Blood · 2018 · 13 citations

Life Sciences, Immunology, Oncology +16

1–3 of 3